Biotest
Works in Cardiovascular · Genetic & rare · Hematology · Immunology · Infectious disease · Respiratory
Biotest is a clinical trial sponsor. It has 1 active clinical trial with 590 planned participants, across 6 therapeutic areas. Since 2021 it has completed 4 trials and stopped 2 early. Its FDA record on file shows compliance actions.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Biotest
No warning letter naming Biotest is on file. FDA has published other compliance actions naming it.
Biotest is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 590 planned participants, in Cardiovascular, Genetic & rare, Hematology, Immunology and other areas. Since 2021 it has completed 4 trials and stopped 2 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Biotest; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-14.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Biotest.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.